MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis

被引:16
|
作者
Liu, Yanli [1 ]
Zhang, Yuchao [2 ]
Li, Qingfu [3 ]
Li, Junfang [2 ]
Ma, Xiaotian [2 ]
Xing, Jinfang [2 ]
Rong, Shouhua [2 ]
Wu, Zhong [4 ]
Tian, Yuan [2 ]
Li, Jing [2 ]
Jia, Liting [2 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 3, Dept Reprod Ctr, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 3, Dept Clin Lab, Zhengzhou, Peoples R China
[3] Peoples Hosp Henan Prov, Dept Stomatol, Zhengzhou, Peoples R China
[4] Henan Univ, Women & Infants Hosp Zhengzhou, Dept Clin Lab, Zhengzhou, Peoples R China
来源
PLOS ONE | 2017年 / 12卷 / 01期
关键词
SUPPRESSES TUMOR PROLIFERATION; HIGH EXPRESSION; POOR-PROGNOSIS; CIRCULATING MICRORNAS; SURVIVAL; BIOMARKERS; SIGNATURE; PATTERNS; MIR-21;
D O I
10.1371/journal.pone.0170088
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose miRNAs are stable and can be extracted from tissues, blood and other body fluid without degradation. miRNAs are abnormally expressed in the presence of a pathological status, including cancer. Therefore, miRNAs are ideal biomarkers for cancer diagnosis and prognosis. Patients with triple negative breast cancer (TNBC) suffer the worst prognosis, although great efforts have been made. Many studies have investigated the role of miRNAs in predicting the outcomes of TNBC patients for better adjustment of treatment. However, results were inconsistent. Thus, we performed a meta-analysis to summarize the published studies for conclusive results. Methods Eligible studies from different database were retrieved from the online databases, and we used STSTA 12.0 to analysis the prognostic role of miRNAs in triple negative breast cancer. Results Overall high miRNA expression indicated a worse survival with HR value of 1.78 (95% CI: 0.97-3.25). However, subtotal HRs of oncogenic miRNAs and tumor suppressive miRNAs were 2.73 (95% CI: 2.08-3.57; P<0.001) and 0.44 (95% CI: 0.21-0.90; P = 0.024), respectively, and no heterogeneity was observed within the subgroups. Conclusions The miRNAs showed a slightly stronger prognostic value for disease-free survival, relapse-free survival and distant metastasis-free survival compared to the overall survival of TNBC patients. Circulating miRNAs could serve as potential biomarkers for the prognosis of TNBC patients and need further investigation.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The Role of miRNAs in the Prognosis of Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
    Santana, Talita Araujo B. da S.
    Passamai, Larissa de Oliveira
    de Miranda, Felipe Silva
    Borin, Thaiz Ferraz
    Borges, Grasiely Faccin
    Luiz, Wilson Barros
    Campos, Luciene Cristina Gastalho
    DIAGNOSTICS, 2023, 13 (01)
  • [2] A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients
    Gui, Yu
    Xu, Shuman
    Yang, Xi
    Gu, Lu
    Zhang, Ze
    Luo, Xiangdong
    Chen, Li
    BIOMARKERS IN MEDICINE, 2016, 10 (07) : 771 - 790
  • [3] MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis (Expression of Concern of Vol 12, art no E0170088, 2017)
    Liu, Y.
    Zhang, Y.
    Li, Q.
    Li, J.
    Ma, X.
    Xing, J.
    PLOS ONE, 2023, 18 (05):
  • [4] Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach
    Naorem, Leimarembi Devi
    Muthaiyan, Mathavan
    Venkatesan, Amouda
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 11768 - 11776
  • [5] Overweight and prognosis in triple-negative breast cancer patients: A systematic review and meta-analysis
    Harborg, K. S.
    Zachariae, R.
    Olsen, J.
    Johannsen, M.
    Cronin-Fenton, D.
    Boggild, H.
    Borgquist, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S43 - S44
  • [6] Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis
    Harborg, Sixten
    Zachariae, Robert
    Olsen, Julia
    Johannsen, Maja
    Cronin-Fenton, Deirdre
    Boggild, Henrik
    Borgquist, Signe
    NPJ BREAST CANCER, 2021, 7 (01)
  • [7] Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis
    Sixten Harborg
    Robert Zachariae
    Julia Olsen
    Maja Johannsen
    Deirdre Cronin-Fenton
    Henrik Bøggild
    Signe Borgquist
    npj Breast Cancer, 7
  • [8] miRNAs in the prognosis of triple-negative breast cancer: A review
    Anilkumar, Kavya, V
    Rema, L. P.
    John, Mithun Chacko
    John, T. Vanesa
    George, Alex
    LIFE SCIENCES, 2023, 333
  • [9] MicroRNAs in the prognosis of triple-negative breast cancer A systematic review and meta-analysis
    Lu, Lingshuang
    Mao, Xuhua
    Shi, Peiyi
    He, Biyu
    Xu, Kun
    Zhang, Simin
    Wang, Jianming
    MEDICINE, 2017, 96 (22)
  • [10] Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
    Petrelli, Fausto
    Bertaglia, Valentina
    Parati, Maria Chiara
    Borgonovo, Karen
    De Silva, Pushpamali
    Luciani, Andrea
    Novello, Silvia
    Scartozzi, Mario
    Emens, Leisha A.
    Solinas, Cinzia
    BREAST, 2023, 67 : 8 - 13